NPI: 1386895886 · WALLA WALLA, WA 99362 · General Acute Care Hospital · NPI assigned 10/02/2008
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY FOR ENROLLMENT) |
| NPI Enumeration Date | 10/02/2008 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 99,967 | $2.72M |
| 2019 | 96,469 | $2.76M |
| 2020 | 86,301 | $2.22M |
| 2021 | 103,009 | $2.56M |
| 2022 | 96,046 | $2.64M |
| 2023 | 82,549 | $2.33M |
| 2024 | 66,854 | $2.12M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 26,965 | 24,038 | $3.22M |
| 96361 | Intravenous infusion, hydration; each additional hour | 8,849 | 7,676 | $2.57M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 21,356 | 18,851 | $2.01M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14,286 | 12,887 | $1.19M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10,199 | 9,652 | $805K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,677 | 4,499 | $728K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6,397 | 4,172 | $685K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,291 | 4,015 | $516K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6,446 | 4,966 | $421K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,231 | 2,155 | $351K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,452 | 2,233 | $329K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,626 | 1,606 | $308K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,894 | 3,649 | $288K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 824 | 817 | $231K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,701 | 1,590 | $209K |
| 80053 | Comprehensive metabolic panel | 35,587 | 29,742 | $198K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 937 | 652 | $186K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6,901 | 5,947 | $183K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,206 | 1,163 | $177K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2,054 | 1,219 | $157K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,012 | 1,944 | $153K |
| 59025 | Fetal non-stress test | 849 | 576 | $120K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,204 | 1,185 | $113K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 259 | 253 | $110K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 40,238 | 32,945 | $96K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,937 | 1,631 | $91K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 650 | 640 | $83K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,984 | 1,975 | $78K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 332 | 325 | $77K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,601 | 2,401 | $73K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2,132 | 1,046 | $63K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 778 | 760 | $60K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,193 | 931 | $46K |
| 95800 | 182 | 181 | $46K | |
| 71046 | Radiologic examination, chest; 2 views | 3,239 | 3,140 | $40K |
| 93971 | 491 | 473 | $39K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 95 | 92 | $38K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 789 | 335 | $36K |
| 84484 | 7,914 | 6,127 | $35K | |
| 76642 | 476 | 441 | $35K | |
| 64483 | 81 | 79 | $33K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 6,666 | 5,742 | $30K |
| 97113 | 796 | 272 | $29K | |
| 84443 | Thyroid stimulating hormone (TSH) | 5,410 | 5,055 | $29K |
| 97535 | Self-care/home management training, each 15 minutes | 1,443 | 1,078 | $25K |
| G0378 | Hospital observation service, per hour | 2,067 | 953 | $24K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 109 | 108 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,826 | 1,766 | $23K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,618 | 1,564 | $23K |
| 73030 | 1,687 | 1,502 | $23K | |
| 76830 | Ultrasound, transvaginal | 1,004 | 987 | $23K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,962 | 4,911 | $22K |
| 93017 | 226 | 222 | $22K | |
| 12001 | 104 | 102 | $21K | |
| 74018 | 1,699 | 1,582 | $21K | |
| 95806 | 39 | 39 | $21K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,958 | 2,447 | $21K |
| 84145 | 2,233 | 2,107 | $21K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3,446 | 3,393 | $21K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,345 | 4,211 | $20K |
| 87040 | 3,236 | 1,727 | $20K | |
| 83605 | 4,979 | 4,352 | $19K | |
| 80050 | General health panel | 2,664 | 2,575 | $18K |
| 80061 | Lipid panel | 4,609 | 4,557 | $17K |
| 71250 | 405 | 392 | $16K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 688 | 366 | $15K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,562 | 1,546 | $15K |
| 82607 | 1,447 | 1,440 | $15K | |
| 76770 | 186 | 186 | $14K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,170 | 1,112 | $14K |
| 72100 | 1,005 | 977 | $14K | |
| 97162 | 399 | 388 | $14K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 52 | 52 | $13K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,984 | 1,975 | $13K |
| 97161 | 331 | 323 | $13K | |
| 73610 | 1,203 | 1,099 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 5,485 | 5,188 | $13K |
| 73562 | 784 | 770 | $12K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,827 | 1,767 | $12K |
| 71045 | Radiologic examination, chest; single view | 8,952 | 8,292 | $11K |
| 82728 | 2,109 | 2,067 | $11K | |
| 83880 | 3,143 | 2,888 | $11K | |
| 73630 | 987 | 903 | $10K | |
| 73130 | 1,013 | 899 | $10K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 384 | 338 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 13,403 | 11,787 | $9K |
| 87186 | 3,266 | 2,845 | $9K | |
| 76801 | 187 | 169 | $9K | |
| 85379 | 1,852 | 1,792 | $9K | |
| 73560 | 799 | 765 | $9K | |
| 86803 | 1,701 | 1,661 | $9K | |
| 81001 | 16,452 | 14,916 | $9K | |
| 87510 | 1,346 | 1,298 | $9K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 43 | 41 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 10,475 | 9,376 | $8K |
| 86140 | 2,775 | 2,535 | $8K | |
| 73110 | 559 | 497 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,894 | 3,923 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | 10,967 | 9,263 | $7K |
| 87070 | 2,213 | 2,092 | $7K | |
| 84439 | 1,558 | 1,522 | $7K | |
| 87077 | 4,225 | 3,630 | $7K | |
| 82570 | 2,130 | 1,898 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,744 | 2,348 | $6K |
| 72141 | 71 | 69 | $6K | |
| 87660 | 1,346 | 1,298 | $6K | |
| 73502 | 496 | 481 | $6K | |
| 85027 | 2,843 | 2,484 | $6K | |
| 83735 | 4,426 | 3,457 | $5K | |
| 96367 | 108 | 78 | $5K | |
| 87480 | 1,346 | 1,298 | $5K | |
| 85651 | 2,527 | 2,345 | $5K | |
| 80143 | 1,472 | 1,291 | $5K | |
| 83540 | 1,617 | 1,577 | $5K | |
| 87631 | 270 | 265 | $5K | |
| 84466 | 1,355 | 1,319 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | 7,659 | 4,190 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | 8,157 | 6,909 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5,560 | 5,234 | $4K |
| 36415 | Collection of venous blood by venipuncture | 7,189 | 5,466 | $4K |
| 84702 | 1,801 | 1,542 | $4K | |
| 85610 | 4,569 | 3,948 | $4K | |
| 85055 | 582 | 495 | $4K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 882 | 873 | $4K |
| 87205 | 1,824 | 1,650 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 24 | 24 | $3K |
| 70486 | 82 | 82 | $3K | |
| 72040 | 199 | 194 | $3K | |
| 10061 | 13 | 13 | $3K | |
| 90715 | 162 | 160 | $3K | |
| 70498 | 52 | 51 | $3K | |
| 83690 | 9,716 | 8,742 | $3K | |
| 82746 | 369 | 369 | $3K | |
| 86592 | 437 | 432 | $2K | |
| 80179 | 1,429 | 1,271 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 85 | 81 | $2K |
| 73140 | 149 | 141 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 6,022 | 4,743 | $2K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 13 | 12 | $2K |
| 70496 | 12 | 12 | $2K | |
| 82043 | 869 | 857 | $2K | |
| 84156 | 806 | 665 | $2K | |
| 93226 | 79 | 78 | $2K | |
| 76536 | 24 | 24 | $2K | |
| 82550 | 778 | 699 | $2K | |
| 81015 | 667 | 629 | $1K | |
| 84703 | 2,348 | 2,261 | $1K | |
| 84403 | 137 | 133 | $1K | |
| 94010 | 39 | 39 | $1K | |
| 72110 | 53 | 53 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 75 | 64 | $1K |
| 71271 | 17 | 16 | $1K | |
| 81003 | 1,838 | 1,777 | $1K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 365 | 356 | $1K |
| J2704 | Injection, propofol, 10 mg | 5,266 | 5,073 | $1K |
| 87081 | 290 | 288 | $1K | |
| 84100 | 538 | 430 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 107 | 88 | $1K |
| 84153 | 203 | 196 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 15 | 15 | $1K |
| 87505 | 36 | 36 | $968.07 | |
| 82962 | 5,492 | 3,521 | $888.67 | |
| 87340 | 348 | 338 | $880.88 | |
| 84481 | 189 | 188 | $873.11 | |
| 93225 | 79 | 78 | $862.39 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,670 | 1,961 | $804.45 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 6,722 | 5,838 | $735.13 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,434 | 8,927 | $686.06 |
| 85018 | 279 | 249 | $679.55 | |
| A9270 | Non-covered item or service | 7,683 | 2,890 | $662.83 |
| 72050 | 27 | 27 | $660.62 | |
| 86850 | 1,070 | 998 | $607.59 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 504 | 493 | $585.24 |
| 80069 | 82 | 78 | $579.14 | |
| 73080 | 53 | 52 | $575.97 | |
| 80076 | 108 | 99 | $559.29 | |
| J3490 | Unclassified drugs | 636 | 572 | $558.98 |
| 82077 | 2,287 | 1,912 | $548.56 | |
| 94729 | 41 | 41 | $547.81 | |
| 86900 | 1,568 | 1,471 | $536.62 | |
| 81025 | 5,359 | 5,124 | $536.08 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 9,847 | 8,391 | $467.66 |
| 86901 | 1,568 | 1,471 | $458.97 | |
| 86706 | 90 | 88 | $438.12 | |
| 87075 | 271 | 256 | $411.98 | |
| 85730 | 700 | 663 | $384.37 | |
| 87506 | 20 | 15 | $367.99 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 11,806 | 10,009 | $339.33 |
| 87899 | 140 | 138 | $332.10 | |
| 83615 | 791 | 586 | $323.23 | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 12 | 12 | $309.62 |
| 83970 | 17 | 17 | $294.65 | |
| 86141 | 343 | 332 | $280.99 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 316 | 293 | $259.65 |
| 86038 | 52 | 52 | $252.73 | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 56 | 29 | $251.83 |
| 73590 | 28 | 24 | $237.56 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,929 | 5,635 | $211.86 |
| 97163 | 12 | 12 | $204.81 | |
| 87634 | 12 | 12 | $191.70 | |
| 87427 | 88 | 61 | $190.10 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 6,500 | 5,673 | $184.05 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 950 | 855 | $176.26 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,983 | 2,480 | $158.71 |
| J1170 | Injection, hydromorphone, up to 4 mg | 6,035 | 4,471 | $147.08 |
| 83525 | 27 | 27 | $128.74 | |
| 90686 | 14 | 14 | $127.54 | |
| 84550 | 61 | 49 | $123.63 | |
| 86704 | 45 | 45 | $122.17 | |
| 82565 | 86 | 78 | $108.74 | |
| 80164 | 14 | 12 | $102.38 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 1,087 | 816 | $74.51 |
| 87045 | 26 | 25 | $73.68 | |
| 36591 | 209 | 122 | $72.40 | |
| 87046 | 48 | 25 | $64.52 | |
| 96376 | 2,379 | 2,099 | $61.30 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,243 | 1,186 | $53.85 |
| 86364 | 12 | 12 | $53.47 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 5,996 | 4,933 | $41.24 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,907 | 2,699 | $40.31 |
| 86708 | 14 | 13 | $39.82 | |
| 87015 | 26 | 25 | $36.88 | |
| 84402 | 12 | 12 | $33.52 | |
| 88304 | 14 | 12 | $29.08 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 897 | 777 | $23.80 |
| J2060 | Injection, lorazepam, 2 mg | 2,646 | 2,214 | $22.18 |
| 85014 | 14 | 12 | $20.80 | |
| 86308 | 12 | 12 | $19.61 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,131 | 2,645 | $17.91 |
| 88342 | 100 | 89 | $15.22 | |
| 0353U | 403 | 398 | $14.70 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,532 | 2,033 | $13.80 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 12 | 12 | $12.20 |
| 94760 | 1,593 | 1,080 | $8.02 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 3,375 | 1,559 | $8.00 |
| 82803 | 13 | 12 | $7.54 | |
| 36600 | 12 | 12 | $3.69 | |
| J1790 | Injection, droperidol, up to 5 mg | 366 | 320 | $1.45 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 817 | 734 | $1.30 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,713 | 1,271 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 258 | 252 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 792 | 721 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 217 | 197 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 113 | 68 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 58 | 58 | $0.00 |
| 0240U | 365 | 357 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 567 | 441 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 58 | 38 | $0.00 |
| C1769 | Guide wire | 85 | 82 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 141 | 76 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 167 | 158 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 13 | 13 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 12 | 12 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 116 | 91 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 904 | 599 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 492 | 464 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 375 | 341 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 13 | 13 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 16 | 13 | $0.00 |
| 99152 | 56 | 51 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 47 | 28 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 89 | 71 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 13 | 12 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 42 | 40 | $0.00 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 135 | 132 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 350 | 323 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 13 | 12 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 35 | 32 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 26 | 12 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 14 | 12 | $0.00 |